- Home
- RVSB vs CNTX Comparison
RVSB vs CNTX Comparison
Compare RVSB & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RVSB | CNTX |
|---|---|---|
| Founded | 1923 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 110.2M | 102.9M |
| IPO Year | 1993 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RVSB | CNTX |
|---|---|---|
| Price | $5.25 | $1.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $7.00 | $5.40 |
| AVG Volume (30 Days) | 39.4K | ★ 322.9K |
| Earning Date | 10-28-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.52% | N/A |
| EPS Growth | ★ 361.12 | N/A |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $52,756,000.00 | N/A |
| Revenue This Year | $10.25 | N/A |
| Revenue Next Year | $11.23 | N/A |
| P/E Ratio | $23.87 | ★ N/A |
| Revenue Growth | ★ 15.20 | N/A |
| 52 Week Low | $4.74 | $0.49 |
| 52 Week High | $6.59 | $1.65 |
Technical Indicators
Market Signals| Indicator | RVSB | CNTX |
|---|---|---|
| Relative Strength Index (RSI) | 50.53 | 43.17 |
| Support Level | $5.17 | $1.00 |
| Resistance Level | $5.31 | $1.18 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 50.63 | 23.56 |
Price Performance
Historical ComparisonAbout RVSB Riverview Bancorp Inc
Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.